Trusted Resources: People & Places
Online groups, photo galleries and blogs
Can Ficicioglu, MD, PhD
Director Lysosomal Storage Diseases Program
Children Hospital of Philadelphia
3401 Civic Center Blvd.
Philadelphia, Pennsylvania, United States
Can Ficicioglu, MD, PhD, is Director of the Newborn Metabolic Screening Program and the Lysosomal Storage Diseases Program, and Clinical Director of the Metabolic Disease Program at Children’s Hospital of Philadelphia. His areas of expertise include Fatty Acid Oxidation Defects, Galactosemia, Lysosomal Storage Disorders, Newborn Metabolic Screening, PKU, etc.
Dr. Can Ficicioglu completed his MD and Internship from University of Istanbul, Cerrahpasa Medical School, Istanbul, Turkey. He completed his residency from Albert Einstein Medical College, Montefiore Hospital and Medical Center, New York Medical College and St. Vincent’s Catholic Medical Center, New York followed by fellowship from Harvard Medical School and Children’s Hospital Boston. Dr. Ficicioglu is board certified in Biochemical Genetics and Pediatrics.
Representative Publications:
Pathogenesis and Treatment of Spine Disease in the Mucopolysaccharidoses
BookmarkRelated Content
-
Beverly L. Davidson, PhDBeverly L. Davidson, PhD, is Director of...
-
Elsa Shapiro, PhDElsa Shapiro, Ph.D., is Professor of Ped...
-
Patricia Dickson, MDDr. Dickson is Division Chief of Genetic...
-
Maria Escolar, MD, MSDr. Escolar is board-certified in neurod...
-
Julie Eisengart, PhD, LPDr. Julie Eisengart is an Associate Prof...
-
Nationwide Newborn Screening Program for Mucopolysaccharidoses in Taiwan and An Update of the “Gold Standard&#...Mucopolysaccharidoses (MPSs) are a group...
-
Single Screening of Newborns for 8 Lysosomal Storage Diseases, Including MPS, PossibleResearchers have developed an efficient ...
